Christoph Bode

12.5k total citations · 1 hit paper
270 papers, 9.1k citations indexed

About

Christoph Bode is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Christoph Bode has authored 270 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Cardiology and Cardiovascular Medicine, 88 papers in Molecular Biology and 61 papers in Surgery. Recurrent topics in Christoph Bode's work include Angiogenesis and VEGF in Cancer (25 papers), Cardiac electrophysiology and arrhythmias (23 papers) and Atherosclerosis and Cardiovascular Diseases (20 papers). Christoph Bode is often cited by papers focused on Angiogenesis and VEGF in Cancer (25 papers), Cardiac electrophysiology and arrhythmias (23 papers) and Atherosclerosis and Cardiovascular Diseases (20 papers). Christoph Bode collaborates with scholars based in Germany, United States and Netherlands. Christoph Bode's co-authors include Martin Moser, Karlheinz Peter, Heiko Bugger, Cam Patterson, Marschall S. Runge, Sebastian Grundmann, Johannes Ruef, W. Kübler, Thomas K. Nordt and Andreas Zirlik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Christoph Bode

258 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic variable stress activates hematopoietic stem cells

2014 575 citations Timo Heidt, Constantin von zur Mühlen et al. profile →

Peers

Countries citing papers authored by Christoph Bode

Since Specialization

Citations

This map shows the geographic impact of Christoph Bode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Bode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Bode more than expected).

Fields of papers citing papers by Christoph Bode

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Bode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Bode. The network helps show where Christoph Bode may publish in the future.

Co-authorship network of co-authors of Christoph Bode

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Bode. A scholar is included among the top collaborators of Christoph Bode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Bode. Christoph Bode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Time from blood draw to multiple electrode aggregometry and association with platelet reactivity 2022 ·Journal of Thrombosis and Thrombolysis ·(unknown), (unknown), (unknown), (unknown), Philipp Diehl, Martin Moser, Christoph Bode, Christoph B. Olivier	6
2	Cardiomyocyte‐specific miR‐100 overexpression preserves heart function under pressure overload in mice and diminishes fatty acid uptake as well as ROS production by direct suppression of Nox4 and CD36 2021 ·The FASEB Journal ·Christian Smolka, (unknown), Christoph Koentges, (unknown), Oliver Gorka, Dietmar Pfeifer, Xavier Bemtgen, (unknown), Olaf Groß, Philipp Diehl, Martin Moser, Christoph Bode, Heiko Bugger, Sebastian Grundmann, Franziska Pankratz	12
3	Eplerenone Improves Pulmonary Vascular Remodeling and Hypertension by Inhibition of the Mineralocorticoid Receptor in Endothelial Cells 2021 ·Hypertension ·(unknown), Lisa X. Deng, (unknown), (unknown), (unknown), Christoph Bode, Lutz Hein, Achim Lother	18
4	MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice 2021 ·Molecular Medicine ·Christian Smolka, (unknown), (unknown), Xavier Bemtgen, (unknown), Laura Schneider, (unknown), Dietmar Pfeifer, Martin Moser, Peter Hasselblatt, Christoph Bode, Sebastian Grundmann, Franziska Pankratz	19
5	Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe mice 2021 ·Molecular Metabolism ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bianca Dufner, Natalie Hoppe, (unknown), Timo Heidt, C Von Zur Muehlen, Peter Stachon, Klaus Ley, Dennis Wolf, Andreas Zirlik, Christoph Bode, Ingo Hilgendorf, Carmen Härdtner	21
6	Docosahexaenoic acid normalizes QT interval in long QT type 2 transgenic rabbit models in a genotype-specific fashion 2021 ·EP Europace ·(unknown), (unknown), Eike M. Wülfers, (unknown), (unknown), (unknown), Marina Rieder, (unknown), Gideon Koren, Zsuzsanna Bösze, András Varró, Manfred Zehender, Michael Brunner, Christoph Bode, Sara I. Liin, H. Peter Larsson, István Baczkó, Katja E. Odening	8
7	Transgenic LQT2, LQT5, and LQT2‐5 rabbit models with decreased repolarisation reserve for prediction of drug‐induced ventricular arrhythmias 2020 ·British Journal of Pharmacology ·(unknown), (unknown), Gerlind Franke, (unknown), (unknown), László Hiripi, Gideon Koren, Zsuzsanna Bösze, András Varró, Manfred Zehender, Michael Brunner, Christoph Bode, István Baczkó, Katja E. Odening	17
8	Extracellular bone morphogenetic protein modulator BMPER and twisted gastrulation homolog 1 preserve arterial‐venous specification in zebrafish blood vessel development and regulate Notch signaling in endothelial cells 2018 ·FEBS Journal ·Jennifer S. Esser, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Cam Patterson, Christoph Bode, Qian Zhou, Martin Moser	13
9	MnTBAP increases BMPR-II expression in endothelial cells and attenuates vascular inflammation 2016 ·Vascular Pharmacology ·Qian Zhou, (unknown), (unknown), (unknown), Franziska Pankratz, Christoph B. Olivier, Christoph Bode, James K. Liao, Martin Moser	9
10	Platelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrel 2016 ·Journal of Thrombosis and Thrombolysis ·Christoph B. Olivier, (unknown), Susanne Weber, Qian Zhou, Christoph Bode, Martin Moser, Philipp Diehl	4
11	The neuronal transcription factor NPAS4 is a strong inducer of sprouting angiogenesis and tip cell formation 2016 ·Cardiovascular Research ·Jennifer S. Esser, (unknown), (unknown), (unknown), Anita L. Allen, Achim Lother, Daniel Epting, Cam Patterson, Christoph Bode, Martin Moser	14
12	A high ratio of ADP–TRAP induced platelet aggregation is associated more strongly with increased mortality after coronary stent implantation than high conventional ADP induced aggregation alone 2014 ·Clinical Research in Cardiology ·Christoph B. Olivier, (unknown), (unknown), (unknown), Manfred Olschewski, Qian Zhou, Christoph Bode, Philipp Diehl, Martin Moser	7
13	Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice 2012 ·Blood ·Daniel Duerschmied, Georgette L. Suidan, Mélanie Demers, Nadine Herr, Carla Carbó, Alexander Brill, Stephen M. Cifuni, Maximilian Mauler, Sanja Cicko, Michael Bäder, Marco Idzko, Christoph Bode, Denisa D. Wagner	253
14	Urine Proteome Analysis Reflects Atherosclerotic Disease in an ApoE−/− Mouse Model and Allows the Discovery of New Candidate Biomarkers in Mouse and Human Atherosclerosis 2012 ·Molecular & Cellular Proteomics ·Constantin von zur Mühlen, Eric Schiffer, (unknown), Petra Zürbig, Irene Neudorfer, Andreas Zirlik, Nay Htun, (unknown), Lothar Jänsch, Harald Mischak, Christoph Bode, Yung‐Chih Chen, Karlheinz Peter	77
15	Abstract 15272: Genetic Deficiency of CD40L Attenuates Diet-Induced Adipose Tissue Inflammation - but Does Not Protect From Insulin Resistance and Hepatic Steatosis in Mice 2011 ·Circulation ·Dennis Wolf, (unknown), Ingo Hilgendorf, Peter Stachon, Christoph J. Binder, Christoph Bode, Andreas Zirlik, Karlheinz Peter	0
16	Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial 2010 ·European Heart Journal ·Benjamin M. Scirica, David A. Morrow, Christoph Bode, Witold Rużyłło, Mikhail Ruda, A. J. M. Oude Ophuis, José López‐Sendón, Karl Swedberg, (unknown), Nader Rifai, Valentina Lukashevich, Mojdeh Maboudian, Christopher P. Cannon, Carolyn H. McCabe, Eugene Braunwald	38
17	Nicorandil normalizes prolonged repolarisation in the first transgenic rabbit model with Long-QT syndrome 1 both in vitro and in vivo 2010 ·European Journal of Pharmacology ·(unknown), (unknown), Katja E. Odening, Stefan Asbach, Gideon Koren, Xuwen Peng, Manfred Zehender, Christoph Bode, Michael Brunner	14
18	Mini-roundabouts: enabling good practice 2006 ·Christoph Bode	1
19	Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia 1999 ·The American Journal of Cardiology ·Karlheinz Peter, Andreas Straub, Benedikt Köhler, Martin Volkmann, Meike Schwarz, W. Kübler, Christoph Bode	56
20	A RECOMBINANT MOLECULE WITH HIGH-AFFINITY FOR FIBRIN EXHIBITS ANTITHROMBIN ACTIVITY AFTER CLEAVAGE BY FACTOR-XA 1994 ·Circulation ·Karlheinz Peter, Amitabh Gupta, Johannes Ruef, M S Runge, Christoph Bode	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact